The traditional model of waiting for advanced disease progression is being replaced by a strategy focused on identifying subtle changes in eye pressure, retinal structure, and lens clarity. This approach allows physicians to intervene when vision remains functionally normal, potentially preventing irreversible damage. Glaucoma treatment serves as a primary example where minimally invasive procedures are now used to lower eye pressure early, safeguarding the optic nerve against silent, progressive harm.
Cataract management is undergoing a similar evolution. Where patients once waited for significant vision impairment, modern techniques now favor earlier intervention to improve quality of life and reduce the long-term reliance on prescription eye drops. This shift decreases the burden of daily medication and helps mitigate side effects associated with chronic treatment regimens.

Comments (0)
No comments yet. Be the first!